Boothbay Fund Management, LLC Renovacor, Inc. Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.12 - $2.18 $56 - $1,024	-470 Reduced 1.47%	31,509 $79,000
Q1 2022 May 16, 2022	SELL	$4.02 - $8.23 $7,710 - $15,785	-1,918 Reduced 5.66%	31,979 $136,000
Q4 2021 Feb 14, 2022	SELL	$6.99 - $9.39 $69,096 - $92,820	-9,885 Reduced 22.58%	33,897 $261,000
Q3 2021 Nov 15, 2021	BUY	$7.73 - $10.65 $338,434 - $466,278	43,782 New	43,782 $396,000

Ticker RCOR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,267,700
Description
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). T...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.